Barclays Maintains Equal-Weight on Scotts Miracle Gro, Lowers Price Target to $60
Portfolio Pulse from Benzinga Newsdesk
Barclays analyst Gaurav Jain has maintained an Equal-Weight rating on Scotts Miracle Gro (NYSE:SMG) and lowered the price target from $70 to $60.
September 05, 2023 | 2:32 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Barclays has maintained an Equal-Weight rating on Scotts Miracle Gro and lowered the price target from $70 to $60.
The lowering of the price target by Barclays from $70 to $60 indicates a potential decrease in the stock's value. This could lead to a negative short-term impact on the stock's price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100